Review




Structured Review

MedCalc Software Ltd cox proportional hazards regression model
Cox Proportional Hazards Regression Model, supplied by MedCalc Software Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cox proportional hazards regression model/product/MedCalc Software Ltd
Average 90 stars, based on 1 article reviews
cox proportional hazards regression model - by Bioz Stars, 2026-04
90/100 stars

Images



Similar Products

90
STATA Corporation power calculation platform for proportional hazards regression (cox model)
Power Calculation Platform For Proportional Hazards Regression (Cox Model), supplied by STATA Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/power calculation platform for proportional hazards regression (cox model)/product/STATA Corporation
Average 90 stars, based on 1 article reviews
power calculation platform for proportional hazards regression (cox model) - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
STATA Corporation cox proportional hazards regression models v15.1
Cox Proportional Hazards Regression Models V15.1, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cox proportional hazards regression models v15.1/product/STATA Corporation
Average 90 stars, based on 1 article reviews
cox proportional hazards regression models v15.1 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
RStudio cox univariable proportional-hazards regression model analysis
Cox Univariable Proportional Hazards Regression Model Analysis, supplied by RStudio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cox univariable proportional-hazards regression model analysis/product/RStudio
Average 90 stars, based on 1 article reviews
cox univariable proportional-hazards regression model analysis - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
MedCalc Software Ltd cox proportional hazards regression model
Cox Proportional Hazards Regression Model, supplied by MedCalc Software Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cox proportional hazards regression model/product/MedCalc Software Ltd
Average 90 stars, based on 1 article reviews
cox proportional hazards regression model - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
GraphPad Software Inc cox proportional hazards regression model graphpad prism 5
Cox Proportional Hazards Regression Model Graphpad Prism 5, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cox proportional hazards regression model graphpad prism 5/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
cox proportional hazards regression model graphpad prism 5 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
GraphPad Software Inc cox regression proportional hazard model
A Schematic illustration of the behavior analysis protocol. At the age of 5 months, six training sessions were conducted for SNCA A53T transgenic mice over 2 weeks. Following the last training, mice were transplanted with NSCs or NSC-shSNCA cells. In a control group (mock), mice were injected with normal saline. NSCs and NSC-shSNCA cells were assessed for their therapeutic effects by B beam walking (mock vs NSC: week 15 to week 13, P < 0.001; mock vs NSC-shSNCA: week 7, P < 0.01, week 5 and 9 to 15, P < 0.001; NSC vs NSC-shSNCA: week 13, P < 0.05, week 15, P < 0.001), C rotarod (mock vs NSC: week 5 to week 15, P < 0.001; mock vs NSC-shSNCA: week 5 to week 15, P < 0.001; NSC vs NSC-shSNCA: NS), D total traveled distance (mock vs NSC: week 13, P < 0.05; mock vs NSC-shSNCA: NS; NSC vs NSC-shSNCA: NS), E locomotion time (mock vs NSC: week 13, P < 0.01, week 15, P < 0.05; mock vs NSC-shSNCA: week 15, P < 0.01; NSC vs NSC-shSNCA: NS), and F rest time (mock vs NSC: week 13 and 15, P < 0.01; mock vs NSC-shSNCA: week 15, P < 0.01; NSC vs NSC-shSNCA: NS). The behavioral assessment was conducted 1 day (week 0) before transplantation and every 7 days thereafter for 22 weeks. Data are presented as mean ± SEM values ( B – F ). Behavioral data were compared by two-way analysis of variance (ANOVA) for time and treatment effects followed by a post hoc Bonferroni test (corrected for multiple comparisons). G Overall survival curves for transplanted mice in the behavior tests. Survival analysis was done using the Kaplan-Meier estimator and the log-rank test for group comparison. Variables with a significant P -value in the univariate analysis were exposed to a multivariate analysis using <t>Cox</t> <t>regression</t> <t>proportional</t> <t>hazard</t> <t>model.</t> GraphPad Prism 5.01 (San Diego, CA, USA) was used for analysis with a significance level of P < 0.05. NS stands for not statistically significant.
Cox Regression Proportional Hazard Model, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cox regression proportional hazard model/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
cox regression proportional hazard model - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

99
STATA Corporation cox proportional hazard regression models
A Schematic illustration of the behavior analysis protocol. At the age of 5 months, six training sessions were conducted for SNCA A53T transgenic mice over 2 weeks. Following the last training, mice were transplanted with NSCs or NSC-shSNCA cells. In a control group (mock), mice were injected with normal saline. NSCs and NSC-shSNCA cells were assessed for their therapeutic effects by B beam walking (mock vs NSC: week 15 to week 13, P < 0.001; mock vs NSC-shSNCA: week 7, P < 0.01, week 5 and 9 to 15, P < 0.001; NSC vs NSC-shSNCA: week 13, P < 0.05, week 15, P < 0.001), C rotarod (mock vs NSC: week 5 to week 15, P < 0.001; mock vs NSC-shSNCA: week 5 to week 15, P < 0.001; NSC vs NSC-shSNCA: NS), D total traveled distance (mock vs NSC: week 13, P < 0.05; mock vs NSC-shSNCA: NS; NSC vs NSC-shSNCA: NS), E locomotion time (mock vs NSC: week 13, P < 0.01, week 15, P < 0.05; mock vs NSC-shSNCA: week 15, P < 0.01; NSC vs NSC-shSNCA: NS), and F rest time (mock vs NSC: week 13 and 15, P < 0.01; mock vs NSC-shSNCA: week 15, P < 0.01; NSC vs NSC-shSNCA: NS). The behavioral assessment was conducted 1 day (week 0) before transplantation and every 7 days thereafter for 22 weeks. Data are presented as mean ± SEM values ( B – F ). Behavioral data were compared by two-way analysis of variance (ANOVA) for time and treatment effects followed by a post hoc Bonferroni test (corrected for multiple comparisons). G Overall survival curves for transplanted mice in the behavior tests. Survival analysis was done using the Kaplan-Meier estimator and the log-rank test for group comparison. Variables with a significant P -value in the univariate analysis were exposed to a multivariate analysis using <t>Cox</t> <t>regression</t> <t>proportional</t> <t>hazard</t> <t>model.</t> GraphPad Prism 5.01 (San Diego, CA, USA) was used for analysis with a significance level of P < 0.05. NS stands for not statistically significant.
Cox Proportional Hazard Regression Models, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 99/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cox proportional hazard regression models/product/STATA Corporation
Average 99 stars, based on 1 article reviews
cox proportional hazard regression models - by Bioz Stars, 2026-04
99/100 stars
  Buy from Supplier

90
GraphPad Software Inc cox proportional hazards regression models graphpad prism 10.2.1
A Schematic illustration of the behavior analysis protocol. At the age of 5 months, six training sessions were conducted for SNCA A53T transgenic mice over 2 weeks. Following the last training, mice were transplanted with NSCs or NSC-shSNCA cells. In a control group (mock), mice were injected with normal saline. NSCs and NSC-shSNCA cells were assessed for their therapeutic effects by B beam walking (mock vs NSC: week 15 to week 13, P < 0.001; mock vs NSC-shSNCA: week 7, P < 0.01, week 5 and 9 to 15, P < 0.001; NSC vs NSC-shSNCA: week 13, P < 0.05, week 15, P < 0.001), C rotarod (mock vs NSC: week 5 to week 15, P < 0.001; mock vs NSC-shSNCA: week 5 to week 15, P < 0.001; NSC vs NSC-shSNCA: NS), D total traveled distance (mock vs NSC: week 13, P < 0.05; mock vs NSC-shSNCA: NS; NSC vs NSC-shSNCA: NS), E locomotion time (mock vs NSC: week 13, P < 0.01, week 15, P < 0.05; mock vs NSC-shSNCA: week 15, P < 0.01; NSC vs NSC-shSNCA: NS), and F rest time (mock vs NSC: week 13 and 15, P < 0.01; mock vs NSC-shSNCA: week 15, P < 0.01; NSC vs NSC-shSNCA: NS). The behavioral assessment was conducted 1 day (week 0) before transplantation and every 7 days thereafter for 22 weeks. Data are presented as mean ± SEM values ( B – F ). Behavioral data were compared by two-way analysis of variance (ANOVA) for time and treatment effects followed by a post hoc Bonferroni test (corrected for multiple comparisons). G Overall survival curves for transplanted mice in the behavior tests. Survival analysis was done using the Kaplan-Meier estimator and the log-rank test for group comparison. Variables with a significant P -value in the univariate analysis were exposed to a multivariate analysis using <t>Cox</t> <t>regression</t> <t>proportional</t> <t>hazard</t> <t>model.</t> GraphPad Prism 5.01 (San Diego, CA, USA) was used for analysis with a significance level of P < 0.05. NS stands for not statistically significant.
Cox Proportional Hazards Regression Models Graphpad Prism 10.2.1, supplied by GraphPad Software Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cox proportional hazards regression models graphpad prism 10.2.1/product/GraphPad Software Inc
Average 90 stars, based on 1 article reviews
cox proportional hazards regression models graphpad prism 10.2.1 - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
SAS institute cox proportional hazards regression model
A Schematic illustration of the behavior analysis protocol. At the age of 5 months, six training sessions were conducted for SNCA A53T transgenic mice over 2 weeks. Following the last training, mice were transplanted with NSCs or NSC-shSNCA cells. In a control group (mock), mice were injected with normal saline. NSCs and NSC-shSNCA cells were assessed for their therapeutic effects by B beam walking (mock vs NSC: week 15 to week 13, P < 0.001; mock vs NSC-shSNCA: week 7, P < 0.01, week 5 and 9 to 15, P < 0.001; NSC vs NSC-shSNCA: week 13, P < 0.05, week 15, P < 0.001), C rotarod (mock vs NSC: week 5 to week 15, P < 0.001; mock vs NSC-shSNCA: week 5 to week 15, P < 0.001; NSC vs NSC-shSNCA: NS), D total traveled distance (mock vs NSC: week 13, P < 0.05; mock vs NSC-shSNCA: NS; NSC vs NSC-shSNCA: NS), E locomotion time (mock vs NSC: week 13, P < 0.01, week 15, P < 0.05; mock vs NSC-shSNCA: week 15, P < 0.01; NSC vs NSC-shSNCA: NS), and F rest time (mock vs NSC: week 13 and 15, P < 0.01; mock vs NSC-shSNCA: week 15, P < 0.01; NSC vs NSC-shSNCA: NS). The behavioral assessment was conducted 1 day (week 0) before transplantation and every 7 days thereafter for 22 weeks. Data are presented as mean ± SEM values ( B – F ). Behavioral data were compared by two-way analysis of variance (ANOVA) for time and treatment effects followed by a post hoc Bonferroni test (corrected for multiple comparisons). G Overall survival curves for transplanted mice in the behavior tests. Survival analysis was done using the Kaplan-Meier estimator and the log-rank test for group comparison. Variables with a significant P -value in the univariate analysis were exposed to a multivariate analysis using <t>Cox</t> <t>regression</t> <t>proportional</t> <t>hazard</t> <t>model.</t> GraphPad Prism 5.01 (San Diego, CA, USA) was used for analysis with a significance level of P < 0.05. NS stands for not statistically significant.
Cox Proportional Hazards Regression Model, supplied by SAS institute, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cox proportional hazards regression model/product/SAS institute
Average 90 stars, based on 1 article reviews
cox proportional hazards regression model - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

90
STATA Corporation cox proportional hazards regression model
A Schematic illustration of the behavior analysis protocol. At the age of 5 months, six training sessions were conducted for SNCA A53T transgenic mice over 2 weeks. Following the last training, mice were transplanted with NSCs or NSC-shSNCA cells. In a control group (mock), mice were injected with normal saline. NSCs and NSC-shSNCA cells were assessed for their therapeutic effects by B beam walking (mock vs NSC: week 15 to week 13, P < 0.001; mock vs NSC-shSNCA: week 7, P < 0.01, week 5 and 9 to 15, P < 0.001; NSC vs NSC-shSNCA: week 13, P < 0.05, week 15, P < 0.001), C rotarod (mock vs NSC: week 5 to week 15, P < 0.001; mock vs NSC-shSNCA: week 5 to week 15, P < 0.001; NSC vs NSC-shSNCA: NS), D total traveled distance (mock vs NSC: week 13, P < 0.05; mock vs NSC-shSNCA: NS; NSC vs NSC-shSNCA: NS), E locomotion time (mock vs NSC: week 13, P < 0.01, week 15, P < 0.05; mock vs NSC-shSNCA: week 15, P < 0.01; NSC vs NSC-shSNCA: NS), and F rest time (mock vs NSC: week 13 and 15, P < 0.01; mock vs NSC-shSNCA: week 15, P < 0.01; NSC vs NSC-shSNCA: NS). The behavioral assessment was conducted 1 day (week 0) before transplantation and every 7 days thereafter for 22 weeks. Data are presented as mean ± SEM values ( B – F ). Behavioral data were compared by two-way analysis of variance (ANOVA) for time and treatment effects followed by a post hoc Bonferroni test (corrected for multiple comparisons). G Overall survival curves for transplanted mice in the behavior tests. Survival analysis was done using the Kaplan-Meier estimator and the log-rank test for group comparison. Variables with a significant P -value in the univariate analysis were exposed to a multivariate analysis using <t>Cox</t> <t>regression</t> <t>proportional</t> <t>hazard</t> <t>model.</t> GraphPad Prism 5.01 (San Diego, CA, USA) was used for analysis with a significance level of P < 0.05. NS stands for not statistically significant.
Cox Proportional Hazards Regression Model, supplied by STATA Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cox proportional hazards regression model/product/STATA Corporation
Average 90 stars, based on 1 article reviews
cox proportional hazards regression model - by Bioz Stars, 2026-04
90/100 stars
  Buy from Supplier

Image Search Results


A Schematic illustration of the behavior analysis protocol. At the age of 5 months, six training sessions were conducted for SNCA A53T transgenic mice over 2 weeks. Following the last training, mice were transplanted with NSCs or NSC-shSNCA cells. In a control group (mock), mice were injected with normal saline. NSCs and NSC-shSNCA cells were assessed for their therapeutic effects by B beam walking (mock vs NSC: week 15 to week 13, P < 0.001; mock vs NSC-shSNCA: week 7, P < 0.01, week 5 and 9 to 15, P < 0.001; NSC vs NSC-shSNCA: week 13, P < 0.05, week 15, P < 0.001), C rotarod (mock vs NSC: week 5 to week 15, P < 0.001; mock vs NSC-shSNCA: week 5 to week 15, P < 0.001; NSC vs NSC-shSNCA: NS), D total traveled distance (mock vs NSC: week 13, P < 0.05; mock vs NSC-shSNCA: NS; NSC vs NSC-shSNCA: NS), E locomotion time (mock vs NSC: week 13, P < 0.01, week 15, P < 0.05; mock vs NSC-shSNCA: week 15, P < 0.01; NSC vs NSC-shSNCA: NS), and F rest time (mock vs NSC: week 13 and 15, P < 0.01; mock vs NSC-shSNCA: week 15, P < 0.01; NSC vs NSC-shSNCA: NS). The behavioral assessment was conducted 1 day (week 0) before transplantation and every 7 days thereafter for 22 weeks. Data are presented as mean ± SEM values ( B – F ). Behavioral data were compared by two-way analysis of variance (ANOVA) for time and treatment effects followed by a post hoc Bonferroni test (corrected for multiple comparisons). G Overall survival curves for transplanted mice in the behavior tests. Survival analysis was done using the Kaplan-Meier estimator and the log-rank test for group comparison. Variables with a significant P -value in the univariate analysis were exposed to a multivariate analysis using Cox regression proportional hazard model. GraphPad Prism 5.01 (San Diego, CA, USA) was used for analysis with a significance level of P < 0.05. NS stands for not statistically significant.

Journal: Cell Death Discovery

Article Title: Neural stem cells derived from α-synuclein-knockdown iPS cells alleviate Parkinson’s disease

doi: 10.1038/s41420-024-02176-z

Figure Lengend Snippet: A Schematic illustration of the behavior analysis protocol. At the age of 5 months, six training sessions were conducted for SNCA A53T transgenic mice over 2 weeks. Following the last training, mice were transplanted with NSCs or NSC-shSNCA cells. In a control group (mock), mice were injected with normal saline. NSCs and NSC-shSNCA cells were assessed for their therapeutic effects by B beam walking (mock vs NSC: week 15 to week 13, P < 0.001; mock vs NSC-shSNCA: week 7, P < 0.01, week 5 and 9 to 15, P < 0.001; NSC vs NSC-shSNCA: week 13, P < 0.05, week 15, P < 0.001), C rotarod (mock vs NSC: week 5 to week 15, P < 0.001; mock vs NSC-shSNCA: week 5 to week 15, P < 0.001; NSC vs NSC-shSNCA: NS), D total traveled distance (mock vs NSC: week 13, P < 0.05; mock vs NSC-shSNCA: NS; NSC vs NSC-shSNCA: NS), E locomotion time (mock vs NSC: week 13, P < 0.01, week 15, P < 0.05; mock vs NSC-shSNCA: week 15, P < 0.01; NSC vs NSC-shSNCA: NS), and F rest time (mock vs NSC: week 13 and 15, P < 0.01; mock vs NSC-shSNCA: week 15, P < 0.01; NSC vs NSC-shSNCA: NS). The behavioral assessment was conducted 1 day (week 0) before transplantation and every 7 days thereafter for 22 weeks. Data are presented as mean ± SEM values ( B – F ). Behavioral data were compared by two-way analysis of variance (ANOVA) for time and treatment effects followed by a post hoc Bonferroni test (corrected for multiple comparisons). G Overall survival curves for transplanted mice in the behavior tests. Survival analysis was done using the Kaplan-Meier estimator and the log-rank test for group comparison. Variables with a significant P -value in the univariate analysis were exposed to a multivariate analysis using Cox regression proportional hazard model. GraphPad Prism 5.01 (San Diego, CA, USA) was used for analysis with a significance level of P < 0.05. NS stands for not statistically significant.

Article Snippet: Variables with a significant P -value in the univariate analysis were exposed to a multivariate analysis using Cox regression proportional hazard model. GraphPad Prism 5.01 (San Diego, CA, USA) was used for analysis with a significance level of P < 0.05.

Techniques: Transgenic Assay, Control, Injection, Saline, Transplantation Assay, Comparison